the ability to dynamically manipulate the transcriptome is important for studying how gene networks direct cellular functions and how network perturbations cause disease. nuclease-dead crisPr-dcas9 transcriptional regulators, while offering an approach for controlling individual gene expression, remain incapable of dynamically coordinating complex transcriptional events. here, we describe a flexible dcas9-based platform for chemical-inducible complex gene regulation. From a screen of chemical-and light-inducible dimerization systems, we identified two potent chemical inducers that mediate efficient gene activation and repression in mammalian cells. We combined these inducers with orthogonal dcas9 regulators to independently control expression of different genes within the same cell. using this platform, we further devised And, or, nAnd, and nor dcas9 logic operators and a diametric regulator that activates gene expression with one inducer and represses with another. this work provides a robust crisPr-dcas9-based platform for enacting complex transcription programs that is suitable for large-scale transcriptome engineering.
The cellular transcriptome is a convergence point that integrates myriad signals to execute biological processes. During development, the transcriptional programs of stem cells coordinate dynamic changes to the mRNA abundance of key genes, driving differentiation into various cell types. Transcriptome disruption is a hallmark of disease. Genome-wide association studies demonstrate that the majority (>93%) of cellular trait-and diseaseassociated variants exist within noncoding DNA, highlighting the essential role of transcriptional regulation in these processes 1, 2 . While techniques such as DNA microarrays and RNA-seq enable reading of the cellular transcriptome 3, 4 , researchers must be able to manipulate transcription in a multiplexed and dynamic fashion in order to establish causal relationships between gene networks and cellular function. Conventional small-molecule-inducible transgene expression systems based on doxycycline or ponasterone A allow manipulation of individual genes 5, 6 , yet they lack complex transcriptional modulation with orthogonal and inducible dcas9 regulators The bacterial CRISPR-Cas9 system is a versatile RNA-guided platform for genome engineering in cell culture or in vivo systems 7 . Nuclease Cas9 protein, when paired with a single guide RNA (sgRNA), can be used to precisely edit genomic DNA [8] [9] [10] [11] . Beyond editing, nuclease-dead Streptococcus pyogenes Cas9 (D10A and H840A), termed dCas9, can be combined with transcriptional activation or repression effectors for sequence-specific constitutive activation or gene repression in mammalian systems [12] [13] [14] [15] [16] [17] . Furthermore, proof-of-concept work has shown that dCas9 can be fused to light-and chemical-inducible domains to conditionally activate gene expression using extrinsic signals [18] [19] [20] . While these inducible dCas9 transcriptional regulators enable regulation of individual genes in isolation, engineering dCas9 regulators that simultaneously utilize multiple inducible systems remains an unexplored area of research. If such inducible systems can act without crosstalk in the same cell, then they can be used in parallel on different dCas9s to dynamically regulate independent gene targets or in combination on a single dCas9 to regulate one target using multiple signals. Given the flexibility and ease of use of CRISPR-Cas9, such advances could provide an approach for the complex regulation of gene expression and for the study of sophisticated gene networks. In addition, the resulting regulators would expand the toolkit of functional parts available for building dCas9-based synthetic gene circuits in mammalian cells 21 .
Here, we present a dCas9-based platform for engineering inducible and orthogonal transcriptional regulators to produce complex transcriptional programs. We systematically explore how dCas9 can be coupled with chemical-and light-inducible domains to dynamically regulate gene activation and repression. These technologies enable the manipulation of multiple gene targets in distinct regulatory patterns and can be utilized for applications requiring reversible and highly specific control over gene transcription such as developmental and disease modeling.
results screening chemical-or light-inducible dcas9s for efficient gene activation
We designed an inducible dCas9-based transcriptional regulation system in which dCas9 and a transcriptional effector are fused to complementary pairs of heterodimerization domains and only assemble in the presence of an extrinsic inducer. To test this design, we systematically fused S. pyogenes (Sp) dCas9 and a VPR (VP64-p65-Rta) activator 22 to six previously reported chemicaland light-inducible heterodimerization domains cloned onto a dual-promoter PiggyBac vector (Supplementary Fig. 1a) . These heterodimerization domains consisted of abscisic acid (ABA)-inducible ABI-PYL1 (ref. 23) , gibberellin (GA)-inducible GID1-GAI 24 , rapamycin-inducible FKBP-FRB 25 , phytochrome-based red light-inducible PHYB-PIF 26 , cryptochrome-based blue lightinducible CRY2PHR-CIBN 27 , and light oxygen voltage-based blue-light-inducible FKF1-GI 28 .
We assessed the activation efficiency of each inducible dCas9 in HEK293T cells by targeting a Tet-On promoter (pTRE3G)-EGFP reporter (Supplementary Fig. 1b) . The most potent systems were the ABA and GA heterodimerization systems, both derived from plant hormone signaling pathways 23, 24 . Upon induction, the ABA-and GA-dimerized VPR-Sp-dCas9-activated EGFP protein expression 165-and 94-fold, respectively (Fig. 1a,b) , efficiencies comparable to that of a VPR-Sp dCas9 direct fusion protein (Supplementary Fig. 2a) . Critically, these inducible dCas9s showed no leaky activation when expressed without inducer. Rather, we observed a minor decrease (10-30%) in EGFP relative to reporter-only cells (Fig. 1a,b) , an effect likely due to steric interference with native transcription factors from dCas9 occupancy on the promoter 12 . Furthermore, addition of inducers to reporter cells without dCas9 elicited no increase in EGFP relative to uninduced cells, excluding nonspecific activation. In contrast, the three light-inducible systems and the rapamycin system showed modest EGFP activation (1.3-to 5.6-fold) upon induction ( Supplementary  Fig. 1c-f) . Previous studies found that light-inducible dimerizing domains exhibit low light sensitivity 29 and highly context-dependent structural folding 30 , which may explain the weak response. In addition, we tested exchanging dimerization domains between the dCas9 and effector domains and found that many inverted dCas9 activators showed poor activity (Supplementary Fig. 3 ). These results suggest that dimerization of the inducible domains may be sensitive to their spatial orientation relative to dCas9.
implementing inducible repression of gene expression
To expand the inducible system to gene repression, we replaced the effector fused to the ABA-or GA-inducible dimerization domains with the Krüppel-associated box (KRAB) repression domain 31 . We assessed inducible repression in HEK293T cells by targeting a constitutive SV40 promoter (pSV40)-EGFP reporter ( Supplementary Fig. 4a ). The ABA-and GA-inducible systems repressed EGFP 5.6-and 3.2-fold, respectively (Fig. 1c,d) , with efficiencies comparable to that of a KRAB-Sp dCas9 direct fusion protein ( Supplementary Fig. 2b ). Binding of dCas9 alone to pSV40 in uninduced cells showed no or only slight reduction of EGFP signals relative to reporter-only cells for either inducible system (Fig. 1c,d ). These results suggest that promoter targeting provides a viable strategy for inducible repression by maximizing the induced repressive effect from KRAB recruitment while minimizing the basal repressive effect of steric hindrance from promoter-bound dCas9 alone.
Staphylococcus aureus inducible dcas9 transcriptional regulators
Recent work showed that a Cas9 protein derived from S. aureus is capable of gene editing 32 and transcriptional activation 33, 34 in mammalian cells. We tested whether our inducible fusion protein design would transfer to nuclease-dead S. aureus Cas9 (Sa dCas9). Both ABA-and GA-inducible activators using Sa dCas9 increased EGFP expression in HEK293T pTRE3G-EGFP cells (Fig. 1e,f) and achieved similar levels of activation as direct fusion VPR-Sa dCas9 (Supplementary Fig. 2c ). However, Sa dCas9 activated EGFP to 20-30% the levels of Sp dCas9 overall, possibly because of differences in sgRNA targeting sequence efficiencies, the lack of a functionally optimized Sa sgRNA scaffold 35 , or intrinsic differences between dCas9 DNA-binding affinities. Nonetheless, retention of gene activation indicates that our fusion design can transfer to multiple Cas9 orthologs.
inducible activation of endogenous genes
We further validated the activity of ABA-inducible Sp dCas9 on an endogenous gene. Here, we introduced individual dCas9 constructs into HEK293T cells along with an sgRNA targeting the CXCR4 gene promoter. We compared activation using the VPR, SunTag-VP64 36 , or combined SunTag-VPR effectors (Fig. 1g) . For these effectors, ABA induction increased CXCR4 protein levels 6.4-to 8.9-fold relative to the levels of uninduced cells. The inability of the combined SunTag-VPR effector to further increase activation efficiency is corroborated by a recent comparative study of multiple Cas9 activator systems 37 .
reversibility and dose responsiveness of ABA-and GA-inducible regulation We subsequently performed detailed dynamic characterizations of the ABA and GA systems. For activation, we monitored EGFP levels over 7 d in HEK293T pTRE3G-EGFP cells stably expressing ABAor GA-inducible Sp VPR-dCas9 as well as in cells expressing the Sa counterparts. In all systems tested, cells under continuous inducer treatment over 7 d maintained high levels of EGFP (Fig. 2a,b) . Removal of the inducer after 2 d triggered a progressive decrease in EGFP levels to baseline, demonstrating reversibility of activation. Furthermore, readdition of inducer in these cells activated EGFP as strongly and rapidly as the original treatment. GA-inducible systems exhibited slower reversal kinetics upon inducer removal (Fig. 2b) , possibly on account of residual GA in the media or slow dissociation of GA-dimerized proteins. The dissociation constant of GA has been estimated to be 10 to 100 times lower than that of ABA 38, 39 . We also quantified dose responses for the four activation systems by measuring EGFP after inducing with varying concentrations of ABA or GA (Fig. 2c,d) . We observed wide linear ranges of ABA and GA responsiveness, implying that dosage can modulate activation strength. At the highest tested dose of GA (100 µM), EGFP levels declined (Fig. 2d) , possibly owing to a cell acidification effect previously described 24 .
We additionally characterized the dynamics of the ABA-inducible KRAB-Sp dCas9 repression system. Similar to activation, ABAinduced repression was maintained over 7 d under continuous treatment (Supplementary Fig. 4b ). Upon removal of ABA, EGFP continued to decrease for 24 h before recovering. We suspect that this delay was caused by the lingering effects of epigenetic modifications initiated by KRAB 40 . ABA-inducible repression also demonstrated dose-responsive behavior, as the repressive effect increased at higher doses (Supplementary Fig. 4c ). Unlike activation, repression was observed at low doses, which may indicate that various transcriptional effectors require different effective concentrations at the promoter to achieve regulation.
orthogonal gene regulation by inducible orthogonal dcas9 regulators
The addition of a second, independently controlled dCas9 transcriptional regulator increases the flexibility and scope of dCas9 tools to allow simultaneous regulation of orthogonal genes. We evaluated whether inducible Sa dCas9 could be used alongside Sp dCas9 in the same cell without crosstalk. To achieve complete orthogonality, two criteria must be met: (i) the two inducers must not cross-activate or interfere with each other; and (ii) each of the dCas9s must not interact with the sgRNAs of the other dCas9 (Supplementary Fig. 5a ).
To address the first criterion, we demonstrated that ABA could not induce heterodimerization of GA-inducible Sp dCas9 and did not interfere with the ability of GA to dimerize GA-inducible Sp dCas9 (Supplementary Fig. 5b) . Conversely, GA did not crossinduce or block dimerization of ABA-inducible Sp dCas9. Next, using different combinations of dCas9 activators and sgRNAs, we showed that gene activation only occurred when Sp dCas9 was expressed with Sp sgRNA or Sa dCas9 was expressed with Sa sgRNA, suggesting the absence of crosstalk between dCas9 orthologs and sgRNAs (Supplementary Fig. 5c,d) .
We then used the constitutive, direct fusion forms of KRAB-Sp dCas9 and VPR-Sa dCas9 to demonstrate simultaneous regulation of two genes, one activated and one repressed. We expressed Sp and/or Sa dCas9 constructs in a HEK293T pSV40-EGFP pTRE3G-mCherry dual reporter cell line along with Sp sgSV40 and/or Sa sgTRE3G (Fig. 3a) . Cells only expressing KRAB-Sp dCas9 and Sp sgSV40 repressed EGFP, while cells only expressing VPR-Sa dCas9 and Sa sgTRE3G activated mCherry. Cells coexpressing both sets of dCas9s and sgRNAs concurrently repressed EGFP and activated mCherry.
Finally, we cointroduced ABA-inducible KRAB-Sp dCas9 and GA-inducible VPR-Sa dCas9 into dual reporter cells along with Sp sgSV40 and Sa sgTRE3G (Fig. 3b) . We observed that cells only induced with ABA repressed EGFP, and cells only induced with GA activated mCherry. Cells given both inducers simultaneously activated mCherry and repressed EGFP. Importantly, 2D flow cytometry plots show that under simultaneous ABA and GA induction, the subpopulation of cells with increased mCherry also exhibited decreased EGFP, confirming that the same cells are responding to both inducers (Supplementary Fig. 6a ).
orthogonal and inducible endogenous gene activation
We further showed that the dCas9 orthologs can independently regulate expression of discrete endogenous gene targets. In HEK293T cells, direct fusion VPR-Sp dCas9 activated CD95 expression, and VPR-Sa dCas9 concurrently activated CXCR4 expression when coexpressed with their respective sgRNAs (Fig. 3c) . When GA-inducible VPR-Sp dCas9 and ABA-inducible VPR-Sa dCas9 were coexpressed instead, GA and ABA could independently trigger activation of CD95 and CXCR4 expression, respectively (Fig. 3d) . 2D flow cytometry plots show that under induction by both GA and ABA, individual cells simultaneously expressed higher levels of CD95 and CXCR4 ( Supplementary  Fig. 6b ). Thus, these results demonstrate that two inducible dCas9 transcriptional regulators can act in one cell in an orthogonal fashion.
coupling multiple chemical-inducible domains for Boolean logic operations
We then looked to expand the vertical flexibility of dCas9 regulators by adding additional layers of inducible control to a single dCas9. Given the robustness of the ABA-and GA-inducible systems, we combined them to generate transcriptional Boolean logic gates. We first created an OR gate by fusing the GA-inducible GAI domain onto the N terminus and the ABA-inducible ABI domain onto the C terminus of Sp dCas9 (Fig. 4a) . When coexpressing this dCas9 protein with both GID1-VPR and PYL1-VPR, HEK293T pTRE3G-EGFP cells showed strong EGFP activation (76-to 139-fold) upon induction with ABA alone, GA alone, or both ABA and GA (Fig. 4a) . We next sought to generate an AND gate by serially linking two heterodimerization domains (Fig. 4b) . The GA-inducible GAI domain was fused to dCas9, the ABA-inducible PYL1 domain to VPR, and the ABI domain to GID1. While cells coexpressing these constructs showed no increase in EGFP when treated with either inducer alone, simultaneous treatment with both inducers produced a 49-fold increase in EGFP (Fig. 4b) . We also exchanged the positions of the ABA-inducible and GA-inducible domains and found retention of AND gate function (Supplementary Fig. 7a) . Furthermore, we used analogous designs to successfully generate NOR and NAND gates by replacing VPR with KRAB, though NAND showed modest repression (Supplementary Fig. 7b,c) . Our results demonstrate an expandable, modular framework for integrating two or more signals into a single dCas9 regulator for logic-based control of gene expression. implementing a dual-input inducible dcas9 for diametric gene regulation Diametric upregulation and downregulation of genes provides a flexible approach for functional interrogation by extending the dynamic range of expression. We created a diametric dCas9 system induced by different inputs to alternatively recruit opposing transcriptional effectors that activate or repress gene expression. This system utilizes the dCas9 from the OR gate coexpressed with GID1-VPR and PYL1-KRAB (Fig. 4c) . In pSV40-EGFP cells, ABA-induced recruitment of KRAB resulted in 2.7-fold EGFP repression, while GA-induced recruitment of VPR resulted in 2.5-fold activation (Fig. 4d) . Interestingly, coinducing with both ABA and GA to simultaneously recruit KRAB and VPR also led to 2.5-fold EGFP repression, suggesting that repression from KRAB may be dominant to activation from VPR. We further characterized this system's ability to switch from an activated to repressed state and vice versa (Fig. 4e) . Replacement of either inducer with the other led to an immediate reversal of the transcriptional regulatory effect, and EGFP levels subsequently passed the basal expression level within 48 h. Compared to simple removal of an inducer from individual activator or repressor systems ( Fig. 2b and Supplementary Fig. 4b) , recruiting an opposing effector accelerated reversal of the initial regulatory effect. discussion Using the ABA and GA chemical-inducible systems, we were able to achieve strong inducible activation of gene expression. Unlike inducible promoter systems and previously generated inducible dCas9s, we detected no leaky activity from our inducible dCas9s.
The inducible dCas9s functioned at levels comparable to directfusion dCas9 activators, with added features for reversible and dose-dependent gene regulation. For repression, KRAB-dCas9 acts additively via dCas9 steric hindrance of RNA polymerase and via KRAB-induced repressive chromatin modifications 12, 13, 40 . In our dimerization strategy, since dCas9 remains DNA bound in the uninduced state, achieving inducible repression relies on minimizing the steric effect while maximizing the chromatin modification effect. This outcome was achieved by constraining sgRNA binding sites to promoter regions upstream of the transcription start site (TSS). Alternative approaches for inducible repression include using a split dCas9 (refs. 20 and 41) or a caging mechanism 42 .
Orthogonal dCas9 systems allow simultaneous activation and repression of different genes in one cell. By further pairing each dCas9 with a discrete inducible system, we enable independent temporal control of each gene target. Inducible and orthogonal dCas9-mediated regulation of discrete genes at different timepoints provides new means to dissect the causal factors that govern complex and dynamic processes such as cell differentiation and oncogenesis (Fig. 5) . The orthogonal dCas9s also immediately permit functional genomic screens based on combinatorial activation and repression, currently limited to activation or repression only. Furthermore, additional dCas9 orthologs or nuclease-dead mutants of the type V CRISPR protein family Cpf1 (ref. 43 ) can be integrated into our platform to increase the sets of genes simultaneously manipulated.
Engineering additional layers of control for individual dCas9 regulators via Boolean logic gates can be useful when manipulating natural gene networks. For example, in the context of gene-based therapeutics, Boolean logic has been used to increase specificity when rewiring natural gene circuits to produce novel functional outputs 44, 45 . Parallel fusion of dimerization domains also enables recruitment of disparate effectors to the same site, as shown by diametric gene regulation. Expanding the method of parallel effector recruitment to other synergistic transcriptional or epigenetic regulators 46, 47 may allow inducible encoding of combinatorial regulatory functions at a target locus and enable fine-tuned control of both magnitude and permanence of target gene expression.
Several proof-of-principle studies have demonstrated that dCas9-based synthetic gene circuits can operate in mammalian cells 34, 48, 49 . In these studies, synthetic circuit regulation was achieved by conditionally expressing sgRNAs from engineered Pol II promoters. A proposed alternative approach is to modulate the activity of dCas9 itself. However, the key challenge in this strategy is developing multiple dCas9 regulators that can act without crosstalk and can be independently regulated 21 . The ABA-and GA-inducible Sp and Sa dCas9 systems developed in this work satisfy both requirements. The Boolean logic gates generated here also offer a protein-based alternative for processing multiple inputs to produce a functional output.
Synthetic biology aims to build complex biological systems from simple biological parts. In this study, we demonstrate a synthetic biology approach for creating a modular dCas9 system that responds to chemical inputs and produces disparate or orthogonal transcriptional outputs. We envision that our system can be expanded into a 'plug-and-play' toolbox to generate a vast array of increasingly complex dCas9 transcriptional regulators, and that it will facilitate engineering the transcriptome to elucidate causal relationships between gene networks and cellular phenotypes. To analyze surface marker expression, cells were instead dissociated using the nonenzymatic reagent Versene (Life Technologies), then stained in 10% FBS in PBS for 1 h at room temperature. Antibodies were purchased from BioLegend (nos. 306510, 400322, 305607, 400111). CXCR4 antibody and isotype were used at 0.4 µg/mL, and CD95 antibody and isotype were used at 0.5 µg/mL.
